Asinercept is an anticancer drug that is administered intravenously and acts by helping the cancer cells to induce their own death by avoiding the proliferation and migration of cancer cells in the brain. If approved, asinercept would provide an alternative treatment to patients that currently do not have other options once the standard of treatment has failed.
Asinercept (Apocept) for glioblastoma multiforme for first or second line
Interventions:
Asunercept (Apocept; APG101)
Indications:
Glioma
Therapeutic Areas:
Neurological Cancer
Year:
2017